Skip to main content
OpenTrials

Clinical trial condition

Urologic Diseases

Explore clinical trials studying Urologic Diseases. Study availability and eligibility vary by location and protocol.

13,807 public trials 2,180 recruiting studies
Refine in advanced search Browse all conditions

Urologic Diseases trial results

Completed

Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)

NCT04193176

Conditions
Chronic Cough, Cough, Female Urogenital Diseases, +14 more
Locations
  • Center for Clinical Trials, LLC ( Site 0021) Paramount, California, United States
  • Health Awareness, Inc. ( Site 0038) Jupiter, Florida, United States
  • Well Pharma Medical Research, Corp. ( Site 0040) Miami, Florida, United States
  • Lenus Research & Medical Group Llc ( Site 0007) Sweetwater, Florida, United States
View all 90 locations
View Trial Details
Completed

A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology

NCT01672775

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • Site US00005 University of Michigan Medical Center Ann Arbor, Michigan, United States
  • Site US00003 Karmanos Cancer Institute Detroit, Michigan, United States
  • Site US00004 Roswell Park Cancer Institute Buffalo, New York, United States
  • Site US00002 Memorial Sloan-Kettering Cancer Center New York, United States
View Trial Details
Completed

A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis

NCT02457221

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Site CN00043 Hefei, Anhui, China
  • Site CN00030 Beijing, Beijing Municipality, China
  • Site CN00034 Beijing, Beijing Municipality, China
  • Site CN00041 Xiamen, Fujian, China
View all 35 locations
View Trial Details
Completed

A Study to Evaluate ASP8232 as Add-On Therapy to Angiotensin Converting Enzyme Inhibitor (ACEi) or Angiotensin Receptor Blocker (ARB) in Reducing Albuminuria in Patients With Type 2 Diabetes and Chronic Kidney Disease

NCT02358096

Conditions
Chronic Disease, Chronic Kidney Disease, Diabetes Mellitus, +17 more
Locations
  • Site CZ42002 Brno, Czechia
  • Site CZ42003 České Budějovice, Czechia
  • Site CZ42005 Prague, Czechia
  • Site CZ42001 Prague, Czechia
View all 57 locations
View Trial Details

Related conditions